Irish Led Study May Help Advance Treatment Of Parkinsons


A team of Irish researchers from CÚRAM led an international study that identified critical targets in the molecular signature of Parkinson's.
Silicon Republic 2:15 pm on April 11, 2024


Featured Image Related to Story

An Irish-led team of scientists has identified critical targets in the molecular signature of Parkinson's disease across different stages. The research, published in PNAS Nexus, provides a complete characterisation of the glycans associated with the connections in the brain affected by Parkinson's. The findings can potentially advance the development of glycan-focused therapeutic devices to treat and diagnose Parkinson's. Prof Abhay Pandit, scientific director of Cram and project lead, said the study will act as a valuable resource for future investigations into neurodegenerative conditions.

  • Irish scientists identify critical targets in molecular signature of Parkinson's disease
  • Study provides complete characterisation of glycans associated with brain connections affected by Parkinson's
  • Findings can potentially advance development of glycan-focused therapeutic devices to treat and diagnose Parkinson's
  • Prof Abhay Pandit: study will act as valuable resource for future investigations into neurodegenerative conditions
  • Research published in PNAS Nexus

https://www.siliconrepublic.com/innovation/parkinsons-molecular-signature-glycans-curam-ireland-study-abhay-pandit

< Previous Story     -     Next Story >

Copy and Copyright Pubcon Inc.
1996-2024 all rights reserved. Privacy Policy.
All trademarks and copyrights held by respective owners.